Status:
UNKNOWN
Age-related Macular Degeneration (AMD) and Cardiovascular Disease
Lead Sponsor:
The New York Eye & Ear Infirmary
Conditions:
Age-related Macular Degeneration
Coronary Artery Disease
Eligibility:
All Genders
50+ years
Brief Summary
The purpose of this research study is to investigate the link between age-related macular degeneration (AMD or ARMD) and coronary artery disease (CAD). Age-related macular degeneration is a medical co...
Detailed Description
The treatment of age-related macular degeneration (AMD), the leading cause of blindness in the developed world, is undergoing a revolution. Intraocular injections of medications that can shut down the...
Eligibility Criteria
Inclusion
- Clinical diagnosis of age-related macular degeneration in at least one eye.
- Patients can have unilateral, but not bilateral CNV. In the case of unilateral CNV, the eye without the CNV will be the study eye.
- Age greater than 50
- Willing and able to comply with clinic visit and study-related procedures
- Provide signed informed consent
- Able to understand and complete study-related questionnaire
- Be able to tolerate dilating drops
Exclusion
- Bilateral CNV
- Other retinal degenerations and retinal vascular diseases such as diabetic retinopathy or macular edema, prior retinal surgery
- Pregnant, lactating, or currently expecting a child
Key Trial Info
Start Date :
August 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04087356
Start Date
August 2 2019
End Date
December 20 2020
Last Update
September 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Eye and Ear Infirmary
New York, New York, United States, 10003